MEET THE FACULTY
Mehdi Ainouche, Ph.D.
Partner
Jeito Capital
Simon Amies
Partner
Cooley
Juan-Camilo Arjona, M.D., Ph.D.
Chief Medical Officer
Organon
Juri Bach, Ph.D.
Senior Investment Manager
HTGF (High-Tech Gründerfonds)
Martina Benešová-Schäfer, Ph.D.
Group Leader, Translational Radiotheranostics
DKFZ
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Steven Biesmans
Principal
UCB Ventures
Jasper Bos, Ph.D.
General Partner
Forbion Growth
Eduardo Bravo
CEO
European Biotech Acquisition Corp.
Roel Bulthuis
Managing Partner
Syncona Investment Management Ltd.
Vanessa Carle, Ph.D.
Principal
Forbion
Hayley Chapman
Executive Director - Operations
Patient Focused Medicines Development (PFMD)
Tomas Cihlar, Ph.D.
SVP of Research, Virology
Gilead Sciences
Bianca Coulter
Executive Chair
Coulter Partners
Laia Crespo-Martin, Ph.D.
Partner
Sanofi Ventures
Nathaniel Dahan, Ph.D.
Senior Associate
Syncona Investment Management
Lisa Dechamps
CEO & Director
AviadoBio
Alexander Demoulin
Principal
Bioqube Ventures
David Di Marcantonio
Global Head of Early Development, Commercial
Parexel
Markus Dietrich, Ph.D.
Senior Investment Associate
Hadean Ventures
Luc Dochez, Pharm.D.
Managing Partner
Droia Ventures
Christian Elling, Ph.D
Managing Partner
Lundbeckfonden BioCapital
Marc Estigarribia
Managing Director
MSQ Ventures
David Feltl, M.D., Ph.D.
Director
National Oncology Center, Czech Republic
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Arthur Franken
General Partner
Gilde Healthcare
Hakan Goker, Ph.D.
Managing Director
M Ventures
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Anja Harmeier, Ph.D.
Head
Roche Venture Fund
Karel Havlicek
1st Deputy Prime Minister and Minister
Ministry of Industry and Trade of the Czech Republic
Miao He, Ph.D.
Senior Investment Associate
Hadean Ventures
Susan Hill, Ph.D.
CEO
Mestag Therapeutics
Regina Hodits, Ph.D.
Managing Director
Angelini Ventures
Alicia (Xia) Hong
VP Business Development Asia
BioNTech
James Huang
Founder & Managing Partner
Panacea Venture
Sophie Hughes, Ph.D.
Investment Analyst
Seroba Life Sciences
Alicia Irurzun-Lafitte
Partner
UCB Ventures
Nadiya Ishnazarova, Ph.D.
Principal, Ventures Investments
Johnson & Johnson Innovation - JJDC Inc.
Christian Kannemeier, Ph.D.
Senior Investment Manager
HTGF (High-Tech Gründerfonds)
Cillian King, Ph.D.
Partner
EQT Life Sciences
Petra Kinzlova
CEO
Prague.bio
Max Klement, Ph.D.
Partner
Novo Holdings
Anja Koenig, Ph.D.
Global Head
Novartis Venture Fund
Zdenek Kovarik
Member of the Prague City Council
Capital City of Prague
Charlotte Kremers, Ph.D.
Principal
M Ventures
Stefano Lamaro
Analyst
Pureos Bioventures
Guru Laxmikanthan, Ph.D.
Partner
Nutter McClennen & Fish LLP
Franck Le Deu
Venture Partner
Aulis Capital
Carla Lema Tomé, Ph.D.
VP, Business Development
Otsuka Pharmaceutical
Elena Lovo, Ph.D.
Executive Director, Head of Life Sciences EMEA
J.P. Morgan
Claire Macht
Director, European Portfolio
EBD Group
Fiona MacLaughlin, Ph.D.
Vice President, Venture Investments
Johnson & Johnson Innovation – JJDC Inc.
Allan Marchington, Ph.D.
Managing Director & Head of Life Sciences
Intermediate Capital Group (ICG)
Magdalena Marciniak
Advisor
i&i Biotech Fund
Ferenc Marofka
Policy Officer
European Commission
Tomáš Maršálek
Founding Partner
i&i Bio
William McKeon
President & CEO
Texas Medical Center
Detlev Mennerich, Ph.D.
Head
Boehringer Ingelheim Venture Fund
Ian Metcalfe
Venture Partner
NLC Health Ventures
Sanjay Mistry, Ph.D.
Vice President, Venture Investments New Company Creation
Johnson & Johnson Innovation – JJDC Inc.
Joep Muijrers, Ph.D.
General Partner
Gilde Healthcare
Søren Møller
Managing Partner, Seed Investments
Novo Holdings
Candace Nagaraja
Managing Director
L.E.K.
Carole Nuechterlein
Former Head
Roche Venture Fund
David Paik, Ph.D.
SVP
Mirae Asset Capital Life Science
Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners
Richard Pazdur, M.D.
Former Director
Oncology Center of Excellence, and Director, CDER, FDA
Laura Pedroza
Associate Director
AbbVie Ventures
Elisa Petris
Lead Partner
Syncona Investment Management
Miloslav Polasek, Ph.D.
Head, Coordination Chemistry Research Group
IOCB Prague
Julie Proft, Ph.D.
Deputy Director
IOCB Tech
Katarina Psenakova, Ph.D.
Head, Biology
PharmTheon
Robert Puopolo
Partner
Goodwin
Guido Rasi, M.D.
Former Executive Director
EMA
Zvonimir Ratkovski
Head of Life Sciences Division
European Investment Fund
Rusty Ray
Managing Director
Alantra
Henrijette Richter, Ph.D.
Managing Partner
Sofinnova Partners
Giovanni Rizzo, Ph.D.
Partner
Indaco BIO Fund
Frederic Scaerou
Head, Global Business Development
Servier
Khoo Shih, Ph.D.
CEO
ClavystBio
Michal Shoshan, Ph.D.
CEO & Founder
metaLead Therapeutic
Kamil Sitarz, Ph.D.
Chief Operating Officer & Board Member
Ryvu Therapeutics
David Stibal, Ph.D.
CEO
i&i Prague
Paul Peter Tak, M.D., Ph.D.
President & CEO
Candel Therapeutics
Ishaan Tewarie
VP
EQT Partners
Noémie Timsit
Associate
Jeito
Emma Tinsley
CEO
Elevara Medicines
Steve Usdin
Washington Editor & Head of Policy & Regulation
BioCentury Inc.
Misti Ushio, Ph.D.
Managing Partner
Digitalis Ventures
Irma Ušinskienė
Head, Clinical Operations
Biomapas
Zuzana Valkova
Science Communication Strategist
IOCB Tech
Ashley van Heteren, Ph.D.
Founder & CEO
Radiogenesis
Lisbeth Van Ruijssevelt, Ph.D.
Associate Partner
McKinsey & Company
Jessica Vitos, Ph.D.
Senior Manager, Innovation
Grifols
Jimmy Wei, Ph.D.
Board Director & CEO
Chime Biologics
Erica Whittaker, Ph.D.
VP & Head Corporate Venture Fund
UCB Ventures
Rob Woodman, Ph.D.
Partner
Panakès Partners
Sue Yao
Co-Head of Licensing and Business Development
Kelun-Biotech and KLUS Pharma
Zhizhong Joel Yao, Ph.D.
Partner
Sofinnova Partners
Alexandra Zemp, Ph.D.
Partner
McKinsey & Company
Dan Zhang, M.D.
Co-Chairman, Hillgene, and former Board Member
BayHelix
Radek Špíšek, Ph.D.
CEO
Sotio Biotech
Past Bio€quity Europe Faculty
Click below to see the 2025 full Faculty list.